Sentinel Node Biopsy for Conjunctival Melanoma; Single Centre Experience and Review of Current Literature.
Barbara PericSpela LeilerGregor HawlinaBoris JancarMarko SnojAndraz PerhavecPublished in: Cancer control : journal of the Moffitt Cancer Center (2022)
Our results confirm that CjM is a rare disease with approximately 14% of positive SLN. At the moment, there are no firm conclusions regarding who would benefit most from SLN biopsy or whether or not CLND should be offered. Data from literature emphasize the need for consistent and uniform staging and future multicentric studies.